Brief: Moderna Reports Q1 EPS Of $ -3.40
01/05/2026 11:30
May 1 (Reuters) - Moderna Inc MRNA.O: MODERNA Q1 REVENUE $389 MILLION VERSUS. IBES ESTIMATE $228.0 MILLION MODERNA Q1 EPS $ -3.40 VERSUS. IBES ESTIMATE $-3.96 MODERNA: LITIGATION SETTLEMENT-RELATED EXPENSES HAD AN IMPACT OF $ 0.9 BILLION ON NET LOSS FOR Q1 MODERNA: COST OF SALES FOR 2026 IS NOW EXPECTED TO BE ABOUT $1.8 BILLION MODERNA: TO RETURN TO SALES GROWTH IN 2026 & EXPECT SEVERAL ADDITIONAL APPROVALS INCLUDING SEASONAL FLU VACCINE MODERNA: YEAR-END CASH & INVESTMENTS FOR 2026 NOW PROJECTED TO BE $4.5 BILLION TO $5.0 BILLION MODERNA: REITERATES PLAN TO DELIVER UP TO 10% REVENUE GROWTH & GAAP OPERATING EXPENSE REDUCTIONS IN 2026 ((Reuters.Briefs@thomsonreuters.com;))